Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI scan could predict pancreatic cancer treatment success

NCT ID NCT06600906

First seen Nov 12, 2025 · Last updated May 23, 2026 · Updated 23 times

Summary

This study tests a special MRI scan that uses an experimental contrast agent called hyperpolarized carbon-13 pyruvate. Unlike standard MRI, this scan shows how tumors process nutrients, which may help doctors predict whether pancreatic cancer treatments are working. The study involves 70 adults with advanced or metastatic pancreatic cancer who will receive the scan before and during standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.